• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PME

PRO MEDICUS LIMITED - Charts / Financials

0.76% ! $305.22
Market Cap $31.80B  !
Healthcare Medical Devices
Add to My Watchlist

Pro Medicus Limited is an Australia-based healthcare informatics company. The Company... Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 13.17pm 21/08/2025 (20 minute delay) ?
Day
Open $301.99   Day High $306.35   Day Low $296.59
Daily Volume 66371
Bids   Sellers
Number Price Volume   Number Price Volume
6 $305.13 35   5 $305.31 26

Directors & Senior Management

Dr. Sam Aaron Hupert Chief Executive Officer, Managing Director, Executive Director
Mr. Clayton James Hatch Chief Financial Officer
Mr. Malte Westerhoff General Manager Europe and Global Chief Technology Officer
Mr. Brad Levin General Manager - North America and Global Head of Marketing
Mr. Danny Tauber General Manager - Australia
Mr. Anthony Barry Hall Technology Director, Executive Director
Ms. Teresa Gschwind Global Head - Customer Service, Visage Imaging
Mr. Sean Lambright Global Head of Sales for Visage Imaging and Vice President Sales, North America
Ms. Sharni Redenbach People and Culture Director
Ms. Danny English Company Secretary
Mr. Peter Terence Kempen Non-Executive Independent Chairman of the Board
Dr. Leigh Farrell Non-Executive Independent Director
Mr. Anthony James Glenning Non-Executive Independent Director
Ms. Deena Robyn Shiff Non-Executive Independent Director
Ms. Alice Joan Morrice Williams Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$305.22 		Change
-2.350(0.76%) 		Mkt cap ! $31.80B
Open High Low Value Volume
$301.99 $306.35 $296.59 $20.06M 66.37K

Buyers (Bids)

No. Vol. Price($)
6 35 $305.13
 

Sellers (Offers)

Price($) Vol. No.
$305.31 26 5
View Market Depth
Last trade - 13.00pm 21/08/2025 (20 minute delay) ?
Last
$304.94 		  Change
-2.350 ( 1.02 %)
Open High Low Volume
$300.84 $306.11 $296.65 6739
Last updated 13.17pm 21/08/2025 ?

Top Stories

Listen: HotCopper Wire Podcast 020 – Forget dreaming, the 9,000s are nearly here

Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 33 epis...
'Sheer scale of exploration opportunity' becomes clear as Gorilla Gold Mines drills at Comet Vale Gorilla Gold Mines (ASX:GG8) has climbed +7% after lauding a "significant" shallow gold discovery at the Happy Jack prospect at Comet Vale.
Artrya Ltd joins top gainers with +36% jump on FDA greenlight Artrya has seen its shares pop +40% in Thursday trades as the company declares a fresh FDA approval that could unlock revenue pathways.
'Not redundant': CBA walks back AI-led job cuts after workload misfire In a backflip, Commonwealth Bank (ASX:CBA) has reversed its call to axe 45 call centre jobs, which had been set to be replaced by AI.
Super Retail Group up +13% after hitting $4.1B in sales, but margins dented Super Retail Group (ASX:SUL) landed a record $4.1B in sales, up 4.5%, proving in a tough retail environment, shoppers are still spending.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.